Novo Nordisk
NVO
$128.64
Share price
2.70%
Change (1 day)
50.92%
Change (1 year)
Categories
Novo Nordisk A / S produces and markets pharmaceutical products and services. Since its founding in Denmark in 1923, the company has developed into a leading company in the diabetes sector worldwide.
Operating Margin for Novo Nordisk (NVO)
Operating Margin as of April 2024 (TTM): 39.02%
According to Novo Nordisk's latest financial reports and stock price the company's current Operating Margin is 39.02%. At the end of 2022 the company had an Operating Margin of 39.03%.
Operating Margin history for Novo Nordisk from 2001 to 2023
Operating Margin at the end of each year
| Year | Operating Margin | Change |
|---|---|---|
| 2022 | 39.03% | -6.99% |
| 2021 | 41.96% | 0.26% |
| 2020 | 41.85% | 5.18% |
| 2019 | 39.79% | -6.55% |
| 2018 | 42.58% | -2.31% |
| 2017 | 43.58% | 1.92% |
| 2016 | 42.76% | 6.13% |
| 2015 | 40.29% | 4.94% |
| 2014 | 38.39% | -1.39% |
| 2013 | 38.94% | 9.24% |
| 2012 | 35.64% | 7.86% |
| 2011 | 33.05% | 9.83% |
| 2010 | 30.09% | 9.87% |
| 2009 | 27.39% | -1.73% |
| 2008 | 27.87% | 6.27% |
| 2007 | 26.22% | 10.88% |
| 2006 | 23.65% | -3% |
| 2005 | 24.38% | -5.05% |
| 2004 | 25.68% | -9.84% |
| 2003 | 28.48% | 13.87% |
| 2002 | 25.01% | -1.37% |
| 2001 | 25.36% |
Operating Margin for similar companies or competitors
| Company | Operating Margin | Operating Margin differencediff. | Country |
|---|---|---|---|
 Pfizer PFE | 34.61% | -11.30% | 🇺🇸 USA |
 Eli Lilly LLY | 24.66% | -36.80% | 🇺🇸 USA |
 Sanofi SNY | 18.21% | -53.33% | 🇫🇷 France |
 Bristol-Myers Squibb BMY | 19.24% | -50.69% | 🇺🇸 USA |
What is a company's Operating Margin
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.